Top in cardiology: Barriers to CV health in women, gender disparities in cardiac surgery
Click Here to Manage Email Alerts
A new review revealed that socioeconomic barriers women face can increase their risk for stroke, myocardial infarction and cardiovascular death. It was the top story in cardiology last week.
Another top story featured an interview with Leslie Cho, MD, director of the Cleveland Clinic’s Women’s Cardiovascular Center, about research on gender disparities in cardiac surgery, including data that show women receive less aggressive cardiovascular (CV) care than men.
Read these and more top stories in cardiology below:
Review: Many women face barriers to optimal CV health early in life
Socioeconomic barriers facing women, including poor access to contraception, postpartum follow-up and maternity leave, can impact their CV health over time, according to a new review. Read more.
Q&A: Cardiac surgery frequently delayed for women, leading to poor outcomes
In the contemporary CV clinical setting, women continue to present later and receive less aggressive care than men and experience a lower quality of life after cardiac surgery, according to an in-depth review published in Circulation. Read more.
Updated AHA dietary guidance encourages intake of fruits, vegetables, whole grains
The American Heart Association has published an updated dietary guidance that outlines 10 recommendations for improving diet quality and cardiometabolic health in the U.S. Read more.
Smoking a marker for lower rates of BP control in patients with hypertension
Smoking cigarettes was associated with lower rates of BP control among patients on medication to treat hypertension, according to an abstract presented at the American College of Cardiology Latin America Conference. Read more.
SURTAVI: TAVR remains noninferior to surgery in intermediate-risk patients at 5 years
Transcatheter aortic valve replacement with a self-expanding valve was noninferior to surgical AVR in intermediate-risk patients at 5 years, according to new data from the SURTAVI trial. Read more.